Hurtling Through the Pandemic at Warp Speed: Lessons Learned and Looking Forward in Biomedical and Healthcare Government Contracting

The US government has awarded billions in contracting dollars through Operation Warp Speed for fighting the COVID-19 pandemic, including multimillion dollar agreements with companies to develop and manufacture vaccines, treatments, devices, and critical inputs. As organizations continue to search for countermeasures to fight an ever-evolving virus, a new presidential administration has taken over, bringing with it new policies, prior government experience, and the need to reconcile these legacy contracting practices.

Join our experienced and battle-tested team—which has been at the forefront of negotiating novel and time-sensitive vaccine, pharmaceutical and healthcare government contracts involving billions in government funding and procurement during the pandemic—for a panel discussion on these issues. Our attorneys will share how deals can vary dramatically in duration, cost and other factors; which factors come into play to affect transactions; and how companies can best position themselves at the negotiating table. They will also cover pricing, commercial distribution, intellectual property rights, liability, and supply chain management issues.

Participants will be able to participate in a Q&A session and are encouraged to submit questions to the panel before the event.